Jae Hwan Oh Selected Research

Rectal Neoplasms (Rectal Cancer)

7/2022	Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study.
1/2022	Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer: multicentre retrospective cohort study.
12/2021	Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Single-Center Experience and Literature Review.
8/2021	Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer.
2/2021	Effect of lateral lymph node dissection on the quality of life and genitourinary function after neoadjuvant chemoradiotherapy for rectal cancer.
1/2021	Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
1/2021	Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A long-term prospective, multicentre, cohort study.
11/2020	Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
9/2020	Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
6/2020	Outcomes of high versus low ligation of the inferior mesenteric artery with lymph node dissection for distal sigmoid colon or rectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae Hwan Oh Research Topics

Disease

81	Rectal Neoplasms (Rectal Cancer) 07/2022 - 02/2008
64	Neoplasms (Cancer) 07/2022 - 11/2003
45	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2004
15	Neoplasm Metastasis (Metastasis) 08/2020 - 11/2003
13	Colonic Neoplasms (Colon Cancer) 11/2022 - 12/2012
4	Adenocarcinoma 01/2018 - 01/2004
4	Flatulence 01/2016 - 09/2013
3	Carcinogenesis 04/2022 - 01/2017
3	Inflammation (Inflammations) 11/2019 - 09/2013
3	Margins of Excision 04/2018 - 07/2010
3	Lymphatic Metastasis 01/2018 - 09/2011
3	Pathologic Complete Response 03/2017 - 12/2010
2	Microsatellite Instability 09/2022 - 02/2015
2	Insulin Resistance 08/2022 - 05/2012
2	Wounds and Injuries (Trauma) 01/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2019 - 01/2018
2	Sigmoid Neoplasms 12/2018 - 09/2013
2	Adenoma (Adenomas) 01/2018 - 05/2012
2	Carcinoma (Carcinomatosis) 02/2015 - 11/2010
2	Hemorrhage 03/2013 - 06/2010
2	Fatigue 04/2012 - 07/2010
2	Cholangiocarcinoma 10/2011 - 11/2003
1	Vomiting 01/2022
1	Appendicitis 10/2021
1	Dehydration (Water Stress) 08/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2020
1	Enteritis 08/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2020
1	Fecal Incontinence 06/2020
1	Peritoneal Neoplasms 02/2020
1	Necrosis 01/2020
1	Polyps 12/2019
1	Diabetes Mellitus 12/2019
1	Hearing Loss (Hearing Impairment) 01/2019
1	Paralysis (Palsy) 01/2019
1	Sensorineural Hearing Loss 01/2019

Drug/Important Bio-Agent (IBA)

12	Carcinoembryonic AntigenIBA 10/2018 - 07/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
5	Capecitabine (Xeloda)FDA Link 01/2018 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 09/2022 - 11/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 09/2005
3	ORALIT (ORS)IBA 01/2022 - 01/2016
3	Leucovorin (Folinic Acid)FDA Link 03/2017 - 09/2005
3	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 09/2005
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2013 - 01/2004
2	Indicators and Reagents (Reagents)IBA 07/2022 - 06/2012
2	LipidsIBA 01/2022 - 10/2011
2	AntioxidantsIBA 01/2022 - 11/2019
2	Coffee FDA Link 01/2022 - 08/2021
2	CarcinogensIBA 08/2020 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 11/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2009
2	IsoflavonesIBA 01/2017 - 01/2015
2	Dietary CalciumIBA 12/2015 - 01/2013
2	CalciumIBA 12/2015 - 01/2013
2	Biological ProductsIBA 02/2015 - 01/2007
2	Fibrinogen (Factor I)FDA Link 01/2015 - 09/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2013 - 01/2013
1	Calcibiotic Root Canal SealerIBA 11/2022
1	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2022
1	AdiponectinIBA 08/2022
1	Insulin (Novolin)FDA Link 04/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2020
1	MercuryIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Hormones (Hormone)IBA 12/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2019
1	TeaIBA 11/2019
1	Capsules (Microcapsules)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019

Therapy/Procedure

53	Chemoradiotherapy 07/2022 - 02/2008
12	Neoadjuvant Therapy 12/2021 - 07/2010
12	Drug Therapy (Chemotherapy) 08/2021 - 01/2004
11	Therapeutics 11/2022 - 01/2004
9	Length of Stay 01/2022 - 03/2013
8	Radiotherapy 10/2018 - 11/2012
6	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 10/2018
5	Colectomy 11/2021 - 03/2013
5	Ileostomy 08/2021 - 07/2010
4	Proctectomy 01/2021 - 07/2010
3	Adjuvant Chemotherapy 07/2015 - 07/2010
2	Stents 01/2022 - 06/2018
2	Salvage Therapy 12/2014 - 11/2010
2	Combination Drug Therapy (Combination Chemotherapy) 09/2005 - 01/2004
1	Enhanced Recovery After Surgery 01/2022
1	Operative Time 01/2022
1	Conservative Treatment 10/2021
1	Hematopoietic Stem Cell Transplantation 08/2020
1	Ligation 06/2020
1	Hyperthermic Intraperitoneal Chemotherapy 02/2020
1	Cytoreduction Surgical Procedures 02/2020
1	Hepatectomy 07/2019